Inflammation, Hypertension, and the Metabolic Syndrome
- 10 December 2003
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 290 (22), 3000-3002
- https://doi.org/10.1001/jama.290.22.3000
Abstract
Opinion from JAMA — Inflammation, Hypertension, and the Metabolic SyndromeKeywords
This publication has 11 references indexed in Scilit:
- Elevated Plasma High-Sensitivity C-Reactive Protein Concentrations in Asian Indians Living in the United StatesJournal of Clinical Endocrinology & Metabolism, 2003
- Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levelsAtherosclerosis, 2003
- Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular DiseaseJournal of Clinical Endocrinology & Metabolism, 2003
- Detecting Vulnerable Plaque Using Peripheral Blood:Journal of Interventional Cardiology, 2003
- C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy American womenACC Current Journal Review, 2003
- Obesity-associated hypertension and kidney diseaseCurrent Opinion in Nephrology and Hypertension, 2003
- Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.Circulation, 2002
- Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial — FAT)Cardiovascular Research, 2001
- Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein LevelsCirculation, 2001
- Hypertension and Associated Metabolic Abnormalities — The Role of Insulin Resistance and the Sympathoadrenal SystemNew England Journal of Medicine, 1996